The pathogenetic and therapeutic implications of the discovery of the immunoglobulin origin of amyloid fibrils.
D000361:Agammaglobulinemia / Q000150:complications; D000595:Amino Acid Sequence; D000682:Amyloid / Q000032:analysis / Q000096:biosynthesis*; D000686:Amyloidosis / Q000150:complications / Q000209:etiology / Q000628:therapy; D001536:Bence Jones Protein / Q000652:urine; D001718:Birefringence; D003224:Congo Red; D006146:Guanidines; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis / Q000378:metabolism*; D066298:In Vitro Techniques; D008247:Lysosomes / Q000378:metabolism; D008854:Microscopy, Electron; D010455:Peptides / Q000032:analysis; D011489:Protein Denaturation; D013194:Staining and Labeling; D014961:X-Ray Diffraction
D000682:Amyloid; D006146:Guanidines; D007136:Immunoglobulins; D010455:Peptides; D003224:Congo Red; D001536:Bence Jones Protein